Figure 4From: Expression of ck-19, galectin-3 and hbme-1 in the differentiation of thyroid lesions: systematic review and diagnostic meta-analysisSROC curve for positive immunocytochemistry expression of CK-19, Gal-3 and HBME-1 in the diagnosis of well-differentiated malignant lesions of the thyroid. Areas under the SROC curve: CK-19=86.32%; Gal-3=97.07%; HBME-1=94.12%.Back to article page